S Waxman Selected Research

marbofloxacin

2/2004	Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats.
2/2003	Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats.
7/2002	Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Waxman Research Topics

Disease

7	Neoplasms (Cancer) 01/2016 - 03/2000
7	Acute Promyelocytic Leukemia 02/2013 - 03/2000
5	Leukemia 09/2008 - 01/2001
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013 - 03/2000
2	Hemorrhage 10/2001 - 12/2000
2	Thrombosis (Thrombus) 10/2001 - 04/2000
2	Carcinoma (Carcinomatosis) 06/2000 - 03/2000
1	Triple Negative Breast Neoplasms 01/2016
1	Adenocarcinoma 01/2016
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2016
1	Wounds and Injuries (Trauma) 03/2009
1	Retinoblastoma (Glioblastoma, Retinal) 09/2008
1	Colorectal Neoplasms (Colorectal Cancer) 02/2007
1	Melanoma (Melanoma, Malignant) 02/2007
1	Body Weight (Weight, Body) 02/2004
1	Fever (Fevers) 02/2003
1	Infections 07/2002
1	Genetic Translocation (Chromosomal Translocation) 10/2001
1	Hematologic Neoplasms (Hematological Malignancy) 10/2001
1	Inflammation (Inflammations) 10/2001
1	Hypertension (High Blood Pressure) 10/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2001
1	Trypanosomiasis 01/2001
1	Sinus Tachycardia 12/2000
1	Tachycardia (Tachyarrhythmias) 12/2000
1	Colonic Neoplasms (Colon Cancer) 06/2000
1	Breast Neoplasms (Breast Cancer) 03/2000
1	Carcinogenesis 03/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2000

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2000
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2006 - 08/2000
4	Arsenic Trioxide (Trisenox)FDA Link 02/2013 - 01/2001
3	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 09/2008 - 01/2001
3	marbofloxacinIBA 02/2004 - 07/2002
3	Pharmaceutical PreparationsIBA 02/2003 - 12/2000
2	Retinoic Acid Receptor alphaIBA 09/2008 - 10/2001
2	Aligeron (AS 2)IBA 06/2006 - 01/2001
2	Vitamin A (Retinol)FDA LinkGeneric 10/2001 - 03/2000
1	Transcription Factors (Transcription Factor)IBA 09/2008
1	Retinoblastoma ProteinIBA 09/2008
1	InterleukinsIBA 02/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2006
1	Methylcellulose (BFL)IBA 06/2006
1	EndotoxinsIBA 02/2003
1	Escherichia coli endotoxinIBA 02/2003
1	Biomarkers (Surrogate Marker)IBA 07/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2001
1	ArsenicIBA 01/2001
1	SolutionsIBA 01/2001
1	esmolol (Brevibloc)FDA LinkGeneric 12/2000
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2000
1	Complementary DNA (cDNA)IBA 08/2000
1	Interferon-gamma (Interferon, gamma)IBA 06/2000
1	Indomethacin (Indometacin)FDA LinkGeneric 06/2000
1	Fluorouracil (Carac)FDA LinkGeneric 06/2000
1	Cytotoxins (Cytolysins)IBA 06/2000
1	Cytostatic AgentsIBA 06/2000
1	retinoic acid receptor betaIBA 03/2000
1	RNA ProbesIBA 03/2000
1	Cellular Retinol-Binding ProteinsIBA 03/2000
1	DigoxigeninIBA 03/2000
1	Steroid Receptors (Steroid Receptor)IBA 03/2000

Therapy/Procedure

8	Therapeutics 07/2011 - 03/2000
2	Drug Therapy (Chemotherapy) 02/2007 - 01/2001
2	Punctures 10/2001 - 04/2000
1	Operative Surgical Procedures 03/2009
1	Radiotherapy 02/2007
1	Intravenous Administration 02/2003
1	Catheters 10/2001
1	Intravenous Infusions 01/2001
1	Mammaplasty (Breast Reconstruction) 03/2000